Healthcare Infection Control Practices Advisory Committee (HICPAC), 19989-19990 [2015-08520]

Download as PDF Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08521 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Time and Date: 2:00 p.m.–3:00 p.m., EST, May 11, 2015. Place: This meeting will be accessible by teleconference. Toll-free +1 (888) 790–1864, Participant Code: 5920580. Status: Open to the public limited only by the availability of telephone ports. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters for Discussion: The agenda will include a follow up discussion on the Draft Guideline for the Prevention of Surgical Site Infections. Call materials will be made available to the public no later than 2 business days before the call. If CDC is unable to post the background material on the HICPAC site prior to the meeting, the background material will be posted on HICPAC’s Web site after the meeting. Background material is available at https:// www.cdc.gov/hicpac. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A–31, Atlanta, Georgia 30333; Email: HICPAC@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and [FR Doc. 2015–08518 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P Board of Scientific Counselors, Office of Infectious Diseases, BSC, OID asabaliauskas on DSK5VPTVN1PROD with NOTICES Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 8:00 a.m.–5:00 p.m., EDT, May 6, 2015. Place: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30333. Status: The meeting is open to the public, limited only by the space available. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: Strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters for Discussion: The meeting will include a report from the Food Safety Modernization Act Surveillance Working Group of the BSC, OID; brief updates on priority issues for CDC’s infectious disease programs; and updates and discussions on CDC’s Surveillance Strategy and the Global Health Security Agenda. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639– 4461. The Director, Management Analysis and Services Office has been delegated Centers for Disease Control and Prevention VerDate Sep<11>2014 17:42 Apr 13, 2015 Jkt 235001 19989 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Initial Review The meeting announced below concerns Comparison and Validation of Screening Tools for Substance Use Among Pregnant Women, DP15–003, initial review. SUMMARY: This document corrects a notice that was published in the Federal Register on March 12, 2015 Volume 80, Number 48, page 13011. The times and dates should read as follows: Times and Dates: 9:00 a.m.–6:00 p.m., April 7–8, 2015 (Closed). M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, Georgia 30341, Telephone: (770)488–3585, EEO6@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. FOR FURTHER INFORMATION CONTACT: Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08519 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) E:\FR\FM\14APN1.SGM 14APN1 19990 Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, M.P.H., Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08520 Filed 4–13–15; 8:45 am] [FR Doc. 2015–08522 Filed 4–13–15; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, SEP; Initial Review Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOA) PS15–001, Positive Health Check Evaluation, and FOA PS15–002, Mobile Messaging Intervention to Present New HIV Prevention Options for MSM. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Special Interest Projects (SIP) 15–001, Integrating Self-Management Education with Cancer Survivorship Care Planning, and SIP 15–003, Using Cancer Registry Data to Promote Proactive Tobacco Cessation among Adult Cancer Survivors. TIMES AND DATES: 10:00 a.m.–6:00 p.m., May 12, 2015 (Closed). 10:00 a.m.–6:00 p.m., May 13, 2015 (Closed). PLACE: Teleconference. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. MATTERS FOR DISCUSSION: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Integrating Self-Management Education with Cancer Survivorship Care Planning, SIP 15–001, and Using Cancer Registry Data to Promote Proactive Tobacco Cessation among Adult Cancer Survivors, SIP 15–003.’’ CONTACT PERSON FOR MORE INFORMATION: Brenda Colley Gilbert, Ph.D., M.S.P.H., Director, Extramural Research Program Operations and Services, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–6295, BJC4@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–08523 Filed 4–13–15; 8:45 am] TIME AND DATE: 10:00 a.m.–5:00 p.m., May 7, 2015 (Closed). PLACE: Teleconference. The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. STATUS: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Positive Health Check Evaluation’’, FOA PS15–001, and ‘‘Mobile Messaging Intervention to Present New HIV Prevention Options for MSM’’, FOA PS15–002. MATTERS FOR DISCUSSION: asabaliauskas on DSK5VPTVN1PROD with NOTICES CONTACT PERSON FOR MORE INFORMATION: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 17:42 Apr 13, 2015 Jkt 235001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Board of Scientific Counselors, National Institute for Occupational Safety and Health, BSC, NIOSH In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: TIME AND DATE: 8:30 a.m.–2:30 p.m., EDT, May 12, 2015. PLACE: Patriots Plaza I, 395 E Street SW., Room 9000, Washington, DC 20201. STATUS: Open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. If you wish to attend in person or by webcast, please see the NIOSH Web site to register (https:// www.cdc.gov/niosh/bsc/) or call (404) 498–2539 at least five business days in advance of the meeting. Teleconference is available toll-free; please dial (888) 397–9578, Participant Pass Code 63257516. PURPOSE: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) E:\FR\FM\14APN1.SGM 14APN1

Agencies

[Federal Register Volume 80, Number 71 (Tuesday, April 14, 2015)]
[Notices]
[Pages 19989-19990]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08520]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting for the aforementioned 
committee:
    Time and Date: 2:00 p.m.-3:00 p.m., EST, May 11, 2015.
    Place: This meeting will be accessible by teleconference. Toll-free 
+1 (888) 790-1864, Participant Code: 5920580.
    Status: Open to the public limited only by the availability of 
telephone ports.
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion, the 
Director, National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID), the Director, CDC, the Secretary, Health and Human Services 
regarding (1) the practice of healthcare infection prevention and 
control; (2) strategies for surveillance, prevention, and control of 
infections, antimicrobial resistance, and related events in settings 
where healthcare is provided; and (3) periodic updating of CDC 
guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters for Discussion: The agenda will include a follow up 
discussion on the Draft Guideline for the Prevention of Surgical Site 
Infections. Call materials will be made available to the public no 
later than 2 business days before the call. If CDC is unable to post 
the background material on the HICPAC site prior to the meeting, the 
background material will be posted on HICPAC's Web site after the 
meeting. Background material is available at https://www.cdc.gov/hicpac.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Erin Stone, M.S., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton 
Road NE., Mailstop A-31, Atlanta, Georgia 30333; Email: HICPAC@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 19990]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Claudette Grant, M.P.H.,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-08520 Filed 4-13-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.